N95.1 ICD-10 Code: Menopausal Symptoms Coding and Billing Guide

Editorial Transparency
Created by: The Billing Service Quotes Editorial Team.
Technical Review: Tim Daniels, Director of Strategic Accounts, Billing Service Quotes

What Is ICD-10 Code N95.1?

ICD-10 code N95.1 is a billable diagnosis code for menopausal and female climacteric states, meaning symptoms such as hot flashes, flushing, sleeplessness, headache, or poor concentration that come with natural, age-related menopause or the perimenopausal transition. It applies only when the patient is symptomatic, and it remains unchanged in the FY2027 code set that took effect October 1, 2026.

N95.1 vs Z78.0: Use N95.1 when menopause causes symptoms the provider documents; Z78.0 reports an asymptomatic menopausal or postmenopausal state, and the two are never billed together.

ICD-10 for hot flashes: Menopausal hot flashes index straight to N95.1, and R23.2 (flushing) or R61 (night sweats) can follow it, since both carry a “code first N95.1” note.

N95.1 vs N95.8: N95.8 covers other specified menopausal disorders, such as a postmenopausal atrophic endometrium, while N95.9 is reserved for a menopausal disorder the record does not describe.

What N95.1 Covers and What It Excludes

One question we hear constantly from practice managers is whether N95.1 simply means postmenopausal. It does not. N95.1 sits in Chapter 14 of ICD-10-CM, within block N80 to N98 and category N95, Menopausal and other perimenopausal disorders, which the FY2027 tabular limits to naturally occurring, age-related menopause and perimenopause. The code describes a symptomatic state: its inclusion note lists flushing, sleeplessness, headache, and lack of concentration associated with natural menopause.

Three layers of notes shape when it applies:

  • At N95.1 (Excludes1): asymptomatic menopausal state (Z78.0), symptoms of artificial menopause (E89.41), and symptoms of premature menopause (E28.310).
  • At category N95 (Excludes1): excessive bleeding in the premenopausal period (N92.4) and disorders due to artificial or premature menopause (E89.4-, E28.31-).
  • At category N95 (Excludes2): postmenopausal osteoporosis (M81.0-), osteoporosis with a current pathological fracture (M80.0-), and postmenopausal urethritis (N34.2), which can be coded with N95.1 when present.

The FY2027 Alphabetic Index sends nine terms to N95.1, including hot flashes, flushing, sleeplessness, and vertigo described as menopausal, along with symptomatic climacteric and menopausal states. Menopause documented without symptoms indexes to Z78.0 instead. Because every one of those index paths depends on the menopause link, the note should tie the symptom to menopause in words, such as “vasomotor symptoms of menopause,” rather than listing the symptom alone.

That distinction matters because several pages ranking for this code describe N95.1 as postmenopausal status or show it with a seventh character such as N95.1A. Neither is correct: postmenopausal status NOS is an inclusion term under Z78.0, and N95.1 is a complete, billable four-character code. Its ICD-9-CM equivalent under the General Equivalence Mappings was 627.2.

What Is the Difference Between N95.1 and Z78.0?

N95.1 reports symptoms of natural menopause that the provider documents and addresses, while Z78.0 reports an asymptomatic menopausal or postmenopausal state. Because N95.1 carries an Excludes1 note for Z78.0, the two are not reported together. A routine exam for a postmenopausal patient without symptoms uses Z78.0; a visit managing hot flashes uses N95.1.

The notes run in one direction. N95.1 lists Z78.0 under Excludes1, while Z78.0 lists symptomatic menopausal state under Excludes2, but the Excludes1 at N95.1 controls, so the pair should not appear on one claim. Two other codes take over when menopause is not natural: E28.310 for symptomatic premature menopause, which clinicians generally define as onset before age 40, and E89.41 for symptoms after surgical or radiation-induced ovarian failure.

Hormone therapy does not change the choice. A patient whose hot flashes are controlled on estradiol still has a condition under active management, so N95.1 stays on the claim with Z79.890, Hormone replacement therapy, to show long-term use.

Here is how N95.1 compares with the codes it is most often confused with:

CodeWhen to use itDocumentation example
N95.1Symptoms of natural menopause or perimenopauseVasomotor symptoms of menopause, starting estradiol patch
Z78.0Menopausal state with no symptoms addressedPostmenopausal, asymptomatic, here for annual exam
N95.0Bleeding after menopausePostmenopausal bleeding, schedule endometrial evaluation
N95.2Atrophic vaginitis after menopauseAtrophic vaginitis, start vaginal estrogen
N95.8Other specified menopausal disorderAtrophic endometrium, postmenopausal
N95.9Menopausal disorder not further describedMenopausal disorder, no detail documented
E28.310Symptomatic premature menopausePremature menopause at 37 with hot flashes
E89.41Symptoms after surgical or radiation menopauseHot flashes after bilateral oophorectomy

What Is the ICD-10 Code for Hot Flashes?

Menopausal hot flashes code to N95.1, because the FY2027 Alphabetic Index sends “hot flashes, menopausal” directly there. When the provider documents flushing or night sweats as separate findings, R23.2 or R61 can follow N95.1, since both codes carry a code-first note for menopausal and female climacteric states.

N95.1 also carries a “use additional code for associated symptoms” instruction, so the classification expects symptom detail when it adds information. Sequencing matters: N95.1 first, then R23.2 for flushing or R61 for night sweats, which is an inclusion term under generalized hyperhidrosis. Sleeplessness and vertigo described as menopausal index to N95.1 itself, so they need no separate code, while a documented depressive episode tied to menopause indexes to F32.89. If the provider documents only possible or suspected perimenopause, outpatient guideline IV.H calls for coding the symptoms, such as R23.2 or R61, rather than N95.1.

Not every hot flash belongs to N95.1. Flushing in a patient whose ovaries were removed codes to E89.41, premature menopause codes to E28.310, and flushing from a non-menopausal cause, such as a medication side effect, is coded to R23.2 with the cause rather than to N95.1. At a follow-up visit, a 52-year-old with documented hot flashes and drenching night sweats who continues estradiol is coded N95.1, R61, and Z79.890.

Nonhormonal treatment has raised the documentation stakes too. Fezolinetant (Veozah), approved by the FDA in 2023, is indicated for moderate to severe vasomotor symptoms due to menopause, so the chart should record frequency, severity, and the effect on sleep or work rather than the diagnosis alone.

How Do You Bill Menopause Visits With N95.1?

Bill menopause management as a problem-oriented office visit, 99212 through 99215, with N95.1 as the diagnosis, leveled by medical decision making or total time. Starting or adjusting hormone therapy involves prescription drug management, which supports moderate risk; at 2026 national rates, a 99214 pays $135.61. Add Z79.890 when hormone therapy is ongoing.

When symptoms come up at an annual exam, the preventive service carries its own diagnosis. Z01.419 or Z01.411 belongs on the preventive code, such as 99396 for an established patient aged 40 to 64, and N95.1 goes on a separately documented 99212 to 99215 with modifier 25 only if the menopause work goes beyond routine counseling. Medicare’s screening pelvic and breast exam, G0101, pays $39.75 nationally in 2026 and is a screening service, so symptom management is billed separately as an E/M.

Procedures follow the same pattern. Hormone pellet insertion reports with 11980, a zero-day global code worth $96.53 nationally in 2026, though payer coverage for pellet therapy varies, so verify before scheduling. A perimenopausal patient who needs contraception or endometrial protection while on estrogen may receive a levonorgestrel IUD, reported with 58300; our CPT 58300 guide covers the device and insertion billing.

On February 12, 2026, the FDA approved labeling changes for six menopausal hormone therapy products that removed cardiovascular disease, breast cancer, and probable dementia statements from the boxed warning, with 29 manufacturers submitting changes. If those changes bring more patients in to discuss hormone therapy, N95.1 and Z79.890 will appear on more claims, so clean documentation is worth setting up now.

In our experience matching providers with billing partners, menopause visits expose documentation gaps quickly, because a note that only says “HRT refill” gives a reviewer little to support the level billed.

Want a billing team that keeps preventive, problem-oriented, and procedure claims straight for menopause care? Billing Service Quotes connects OB-GYN practices with medical billing companies within 30 minutes of a request, at no cost.

Postmenopausal Bleeding, Atrophy, and Bone Health

Providers often come to us after a run of denials on postmenopausal workups that were coded with N95.1 out of habit. N95.1 covers symptoms, not every condition that follows menopause. Bleeding after menopause has its own code, N95.0, and it usually drives a workup: a transvaginal ultrasound (76830), an endometrial biopsy (58100), or, when the lining or a polyp needs a direct look, hysteroscopy with biopsy or polypectomy (58558). Our CPT 58558 guide covers that procedure, which pays $1,269.90 nationally in the office in 2026. Keep the bleeding code on those claims, because it is what supports the medical necessity of each test.

Vaginal dryness and atrophic change after menopause code to N95.2, Postmenopausal atrophic vaginitis, which also covers senile vaginitis. When a patient has both vasomotor symptoms and atrophic vaginitis, N95.1 and N95.2 can be reported together, each pointed to the service that addresses it. Genitourinary symptoms grouped clinically as genitourinary syndrome of menopause still code by the documented findings, such as N95.2. Atrophy of the cervix described as menopausal, and an atrophic endometrium after menopause, index to N95.8.

Bone health sits outside category N95 entirely. Postmenopausal osteoporosis (M81.0) is an Excludes2 condition, so it can be coded with N95.1 when both are documented, and osteopenia codes to M85.8- instead. Medicare covers bone density testing generally once every 24 months for an estrogen-deficient woman at clinical risk for osteoporosis, and an axial DXA (77080) pays $39.41 nationally in 2026, so the order should state the estrogen deficiency and the risk factors behind it.

Why Do Claims With N95.1 Get Denied?

Claims with N95.1 often deny over code conflicts and sequencing rather than the code itself. Common causes include reporting N95.1 with Z78.0, using N95.1 for surgical or premature menopause, putting N95.1 first on a preventive service, and sequencing a symptom code such as R23.2 ahead of it.

Watch for these seven errors:

  1. Pairing N95.1 with Z78.0. The Excludes1 note at N95.1 means the two should not appear on the same claim.
  2. Coding surgical menopause as N95.1. Symptoms after oophorectomy or pelvic radiation belong to E89.41.
  3. Coding premature menopause as N95.1. Symptomatic premature menopause has its own code, E28.310.
  4. Billing the category or an invalid extension. N95 is not billable, and N95.1 takes no seventh character.
  5. Leading a preventive claim with N95.1. Z01.419 or Z01.411 supports the preventive code, while N95.1 belongs on the modifier 25 problem visit.
  6. Sequencing R23.2 or R61 first. Both carry code-first notes that put N95.1 ahead of them.
  7. Using N95.9 when the record names the symptoms. Unspecified codes invite review when the note supports N95.1.

Several of these errors live in templates and favorites lists rather than in individual coding decisions, so a one-time review of menopause templates fixes them in bulk.

The most common issue we see providers run into is an EHR problem list that carries Z78.0 forward for every postmenopausal patient, so it lands on claims next to N95.1. Consider a practice that bills 40 hormone therapy follow-ups a month at 99214. If the template attaches both codes, every one of those claims can trip an Excludes1 edit, putting $5,424.40 a month at risk at the 2026 national rate, or $65,092.80 a year.

Frequently Asked Questions

Is N95.1 a billable ICD-10 code?

Yes. N95.1 is a billable ICD-10-CM code at four characters, valid for dates of service from October 1, 2026 through September 30, 2027. It takes no fifth, sixth, or seventh character. The category code N95 is not billable, so claims must carry N95.1 or another complete code in the category.

Can N95.1 be used for perimenopause?

Yes, when the patient has symptoms. Category N95 covers disorders of naturally occurring menopause and perimenopause, and the index sends symptomatic climacteric states to N95.1. Heavy bleeding in the premenopausal period is a different problem and codes to N92.4, which the N95 category excludes.

What is the ICD-10 code for surgical menopause symptoms?

Use E89.41, Symptomatic postprocedural ovarian failure, for flushing, sleeplessness, headache, or poor concentration after surgical or radiation-induced menopause. E89.40 covers the asymptomatic state. N95.1 excludes symptoms of artificial menopause, so it should not be used after a bilateral oophorectomy, even when the symptoms match natural menopause.

Can N95.1 and Z79.890 be billed together?

Yes. Z79.890, Hormone replacement therapy, reports long-term current use of hormone therapy, while N95.1 reports the menopausal symptoms being managed. Listing both tells the payer why the visit happened and what treatment the patient is on, which supports medical necessity for monitoring visits and related labs.

What was the ICD-9 code for N95.1?

Under the General Equivalence Mappings, N95.1 corresponds to ICD-9-CM code 627.2, Symptomatic menopausal or female climacteric states. ICD-9 codes have not been valid for services on or after October 1, 2015, so 627.2 matters only when reviewing older records or historical claims data.

Does Medicare cover menopause visits coded with N95.1?

Medicare Part B covers medically necessary office visits that evaluate and manage menopausal symptoms, billed as problem-oriented E/M services with N95.1. It does not cover routine physical exams. Prescription hormone therapy is generally a Part D pharmacy benefit, so drug coverage questions go to the patient’s drug plan.

Next Steps

Clean menopause claims start with the right billing partner. Billing Service Quotes has matched about 2,000 providers with medical billing companies, with rates starting as low as 2.95%, and matching is 100% free.

Share This :

Get Matched In 30 Minutes

Get a FREE Quote

Tell us about your practice and we'll connect you with trusted billing companies.

100% Free to providers — No hidden fees at any stage

Where should we send your quote(s)?

We'll send it directly to your inbox

How many providers does your practice have?

We'll find a billing company that can support your needs

Where is your practice located?

We'll find a billing company that serves providers in your area

loading
Tim Daniels
Online now
Tim Daniels

How can I help?

Send me your number and I'll personally call you in less than 24 hours to discuss any questions you may have about our OB/GYN billing partners

Mon–Fri, 9:00am–5:30pm Or email instead →
Got it — talk soon.
I'll call you within one business hour. Check your phone for an unknown number.